Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 11, doi. 10.1007/s40290-015-0082-x
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2015 AND VI 29 AND IP 1
Results: 7
1
2
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 63, doi. 10.1007/s40290-015-0083-9
- Publication type:
- Article
3
Forum.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 51, doi. 10.1007/s40290-015-0084-8
- Publication type:
- Article
4
Clinical Trials Using Mobile Health Applications.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 17, doi. 10.1007/s40290-015-0085-7
- By:
- Publication type:
- Article
5
Drugs in Clinical Development for Malignant Melanoma: Summary and Table.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 27, doi. 10.1007/s40290-015-0086-6
- Publication type:
- Article
6
Making the Proper Choices on Education for the Pharmaceutical Industry.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 7, doi. 10.1007/s40290-015-0087-5
- By:
- Publication type:
- Article
7
Do Molecular Structures of Migraine Drugs Point to a Common Cause of this Elusive Disease and Suggest Future Drug Designs?
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 1, p. 1, doi. 10.1007/s40290-014-0075-1
- By:
- Publication type:
- Article